Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Global Kinetics (formerly Movement Disorder Technologies) is a commercial-stage digital health company that developed the Personal KinetiGraph (PKG), a wearable system for the objective monitoring of Parkinson's disease. The PKG system consists of a wrist-worn sensor that continuously records movement data, which is then processed using proprietary algorithms to provide clinicians with detailed reports on bradykinesia, dyskinesia, and tremor. This objective data allows for more precise medication adjustments and improved management of motor symptoms compared to traditional subjective clinical assessments. Headquartered in Melbourne, Australia, the company has received regulatory clearances in major markets including the US (FDA), Europe (CE Mark), and Australia (TGA).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Movement Disorder Technologies.